Abstract: To provide a method for producing a phosphoryl imide salt represented by the following general formula (1) at a satisfactory yield by cation exchange. The method comprises the step of performing cation exchange by bringing a phosphoryl imide salt represented by the following general formula (2) into contact with a cation exchange resin having M1 n+ or a metal salt represented by the general formula (4) in an organic solvent having a water content of 0.3% by mass or less.
Abstract: The present invention is related to a process for preparing safinamide and salts thereof, preferably safinamide methanesulfonate, with high yields and high enantiomeric and chemical purity without the need of using highly pure intermediates. The process of the present invention is suitable for the production of safinamide and its salts, preferably safinamide methanesulfonate, at industrial scale.
Type:
Grant
Filed:
August 5, 2020
Date of Patent:
January 18, 2022
Assignee:
MEDICHEM, S.A.
Inventors:
Yisong Wen, David Font Gimbernat, Ernesto Durán López
Abstract: A process for the production of concentrated aqueous solutions of hydrazine hydrate includes preparation of hydrazine hydrate by a ketazine method using 50-70% hydrogen peroxide, recyclable solid acetamide and ammonium acetate activator for ketazine formation, and catalyst-free hydrolysis of ketazine to provide aqueous solutions of hydrazine hydrate in an energy efficient manner.
Type:
Grant
Filed:
September 28, 2017
Date of Patent:
January 18, 2022
Assignees:
Council of Scientific & Industrial Research, Gujarat Alkalies and Chemicals Limited
Abstract: The present invention relates to a process for in situ the preparation of mixtures of chelating agents by catalyzed reactions of diethanolamine derivatives with maleic acid and then with 2-halocarboxylic acid, to mixtures of chelating agents and methods using such chelating agents.
Type:
Grant
Filed:
June 27, 2018
Date of Patent:
January 18, 2022
Assignee:
Kemira Oyj
Inventors:
Reijo Aksela, Jonas Konn, Anna-Maija Perander, Anna Haarala, Riitta Ilmoniemi, Hanna Hoffren
Abstract: Through the use of a rhodamine appended chelate, a versatile strategy has been demonstrated to generate mitochondria-targeting photosensitizers via the incorporation of variety of luminescent transition metal systems. The generation of triplet excited state of rhodamine moiety endows the complexes with mitochondria-targeting photosensitizing ability to form singlet oxygen (1O2) for use as photodynamic therapy (PDT) agent. The combination of rhodamine organic dye and luminescent transition metal centers in such hybrid systems exhibits the synergistic merits, including low dark cytotoxicity, selective tumor cell uptake, high molar absorptivity for low-energy excitation in the visible region, and high photostability.
Type:
Grant
Filed:
August 16, 2018
Date of Patent:
January 4, 2022
Assignees:
SOUTHERN UNIVERSITY OF SCIENCE AND TECHNOLOGY, SHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY CHINESE ACADEMY OF SCIENCES
Inventors:
Keith Man Chung Wong, Chuangjun Liu, Ping Gong, Lihua Zhou, Lintao Cai
Abstract: The present disclosure relates to a process for producing high-purity acrylic acid using a dividing wall distillation column and in some instances using water as an entrainer and azeotroping agent. This disclosure provides a process for separating acrylic acid from recovered feed streams which comprise saturated organic acids including propionic acid. The resulting acrylic acid product is of sufficient purity to produce acrylate esters and high molecular weight acrylic acid polymers.
Type:
Grant
Filed:
December 15, 2017
Date of Patent:
January 4, 2022
Assignee:
Eastman Chemical Company
Inventors:
Craig Alan Hoyme, Robert Scott Huss, Joseph Jerome Puhr
Abstract: The invention provides compounds having the general formula I: and pharmaceutically acceptable salts thereof, wherein the variables RA, RAA, subscript n, ring A, X2, L, subscript m, X1, ring B, R1, and RN have the meaning as described herein, and compositions containing such compounds and methods for using such compounds and compositions.
Inventors:
Sultan Chowdhury, Christoph Martin Dehnhardt, Thilo Focken, Michael Edward Grimwood, Ivan William Hemeon, Steven McKerrall, Daniel Sutherlin
Abstract: Process for hydrogenating aromatic compounds over a solid catalyst in the presence of a hydrogen-containing gas comprising a first reactor operated in loop mode, a second reactor operated in straight pass, at least part of the output of the first reactor is supplied to the second reactor, characterized in that the first reactor is configured as a trickle bed reactor and is operated in trickle bed mode and the second reactor is operated such that the catalyst present therein is partially flooded.
Abstract: Provided herein are methods and intermediates for making (1R,2R,5R)-5-amino-2-methylcyclohexanol hydrochloride, which are useful for the preparation of compounds useful for the treatment of a disease, disorder, or condition associated with the JNK pathway.
Abstract: A compound of general formula (I) or (II), wherein Rn and Rm independently represent a C3-C27 aliphatic group, R1 to R4, which may be the same or different at each occurrence, represent hydrogen or a C1-C8 alkyl group, X1 and X2, which may be the same or different at each occurrence, represent a linear or branched divalent hydrocarbon radical with 1 to 24 carbon atoms which can be optionally substituted and/or interrupted by one or more heteroatoms or heteroatom containing groups, and R5 and R6, which may be the same or different at each occurrence, represent a group selected from —O?, -Alk-CH(OH)—CH2—SO3— and -Alk-CO2— wherein Alk represents an alkylene group.
Type:
Grant
Filed:
November 8, 2017
Date of Patent:
November 30, 2021
Assignee:
RHODIA OPERATIONS
Inventors:
Olivier Back, Roberto Company, Hong Liu, Rémy Leroy, Philippe Marion
Abstract: An object of the present invention to provide a method for producing methionine with consideration given to the environment. The production method of the present invention comprises a removal step of blowing an inert gas into a liquid containing 5-(2-methylmercaptoethyl)hydantoin and thereby diffusing ammonia remaining in the liquid to obtain an emission gas containing the ammonia, and a recovery step of bringing the emission gas into contact with a washing liquid to recover ammonia contained in the emission gas.
Abstract: A method of reducing impurities in a catalyst for the production of purified terephthalic acid includes forming purified terephthalic acid by hydrogenating crude terephthalic acid with a catalyst in a reactor; separating the purified terephthalic acid from the catalyst and reactivating the catalyst by washing with a caustic solution; and flushing the catalyst contaminated with impurities with a non-caustic liquid at a flushing temperature of greater than or equal to 50° C.
Type:
Grant
Filed:
August 9, 2018
Date of Patent:
November 23, 2021
Assignee:
SABIC GLOBAL TECHNOLOGIES B.V.
Inventors:
Syed Azhar Hashmi, Sankaran B. Nedumbamana, Paresh Bhagvanbhai Rasadiya
Abstract: This invention relates to compounds that are useful as inhibitors, in particular as inhibitors of Cathepsin K (CatK), and to a method of inhibiting cathepsin activity, comprising administering a compound or formulation comprising a compound according to the invention.
Abstract: An aromatic amine compound capable of satisfactorily forming a cured product having exceptional alkali resistance by reaction with an epoxy compound; a curing agent for an epoxy compound, the curing agent including the aromatic amine compound; a curable composition including the curing agent for an epoxy compound; a cured product of the curable composition; a method for producing the cured product; and a method for producing the abovementioned aromatic amine compound. The aromatic amine compound has a structure such that a specific position in a central skeleton comprising a fused ring such as a fluorene ring is substituted with a side-chain group including two aromatic groups linked by a flexible bond such as an amide bond, at least one amino group is bonded to the end of the side-chain group, and the structure has no hydroxyl groups.
Abstract: Disclosed are novel conjugates and processes for the preparation thereof. A process tor the preparation of alkene- or alkyne-phosphonamidates comprises the steps of (I) reacting a compound of formula (III), with an azide of formula (IV), to prepare a compound of formula (V), reacting a compound of formula (V) with a thiol-containing molecule of formula (VI), resulting in a compound of formula (VII).
Type:
Grant
Filed:
September 1, 2017
Date of Patent:
November 2, 2021
Assignees:
FORSCHUNGSVERBUND BERLIN E.V., LUDWIG-MAXIMILIANS-UNIVERSITÄT MÜNCHEN
Inventors:
Christian Hackenberger, Marc André Kasper, Maria Glanz, Tom Sauer, Dominik Schumacher, Jonas Helma-Smets, Heinrich Leonhardt, Andreas Stengl
Abstract: There is disclosed a cyclic process for producing taurine from monoethanolamine comprising the steps of: (a) reacting monoethanolamine with ammonium sulfate in the recycling mother liquor to yield monoethanolamine sulfate; (b) reacting the monoethanolamine sulfate with sulfuric acid to form 2-aminoethyl hydrogen sulfate ester; (c) subjecting the 2-aminoethyl hydrogen sulfate ester to a sulfonation reaction with ammonium sulfite to yield taurine and ammonium sulfate; (d) separating the taurine and the ammonium sulfate by means of solid-liquid separation; (e) removing the excess ammonium sulfite from the mother liquor to obtain an aqueous solution comprised of ammonium sulfate and (f) returning the aqueous solution to step (a) to complete the cyclic process.
Abstract: A compound with anti-drug resistant bacteria activity having the following formula (I) is disclosed. A method of preparing the compound of formula (I) is also disclosed.
Type:
Grant
Filed:
December 19, 2020
Date of Patent:
October 26, 2021
Assignee:
SHAANXI UNIVERSITY OF SCIENCE AND TECHNOLOGY
Inventors:
Bin Tian, Juan Li, Nan Hui, Guaiping Qiao, Liang Xin, Jingyi Li, Dan Yang, Han Li, Yanjun Li, Liang Qi, Wenbo Yao, Chengyuan Liang
Abstract: A magnesium citrate glycinate co-salt has a formula of Mg2C8H9NO9—XH2O and a suggested structure of: The magnesium citrate glycinate co-salt has an apparent density of 1740 kg/m3 and is compressible in a range of compression pressures from approximately 50 MPa to approximately 150 MPa. The magnesium citrate glycinate co-salt is formed by combining citric acid and glycine in a 1:1 molar ratio to form an aqueous reaction mixture and neutralizing the aqueous reaction mixture with a magnesium source having a magnesium:ligand ratio of 1:1.
Abstract: A process for preparation of 4-aminoindane compounds of a first formula, salts and enantiomers thereof including: a) hydrogenating a 1,2-dihydroquinoline of a second formula to give a corresponding tetrahydroquinoline of a third formula; b) acylating the tetrahydroquinoline of the third formula with a carboxylic acid derivative of a fourth formula to obtain a corresponding acyl derivative compound of a fifth formula; c) rearranging the acyl derivative compound of the fifth formula under acidic conditions so as to give an acyl indane compound of a sixth formula or an addition salt thereof; and d) hydrolysing the acyl group of the acyl indane compound of the sixth formula so as to obtain the 4-aminoindane derivatives of the first formula.